Erratum: CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells (Leukemia (2009) vol. 23 (1329-1336) 10.1038/leukemia.2009.77)

A. Takeshita; N. Yamakage; K. Shinjo; T. Ono; I. Hirano; S. Nakamura; K. Shigeno; T. Tobita; M. Maekawa; H. Kiyoi; T. Naoe; K. Ohnishi; Y. Sugimoto; R. Ohno

doi:10.1038/leu.2009.115

Erratum: CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells (Leukemia (2009) vol. 23 (1329-1336) 10.1038/leukemia.2009.77)

A. Takeshita, N. Yamakage, K. Shinjo, T. Ono, I. Hirano, S. Nakamura, K. Shigeno, T. Tobita, M. Maekawa, H. Kiyoi, T. Naoe, K. Ohnishi, Y. Sugimoto, R. Ohno

研究成果: Comment/debate › 査読

1 被引用数 (Scopus)

本文言語	English
ページ（範囲）	1372
ページ数	1
ジャーナル	Leukemia
巻	23
号	7
DOI	https://doi.org/10.1038/leu.2009.115
出版ステータス	Published - 2009
外部発表	はい

ASJC Scopus subject areas

血液学
腫瘍学
癌研究

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1038/leu.2009.115

他のファイルとリンク

引用スタイル

Takeshita, A., Yamakage, N., Shinjo, K., Ono, T., Hirano, I., Nakamura, S., Shigeno, K., Tobita, T., Maekawa, M., Kiyoi, H., Naoe, T., Ohnishi, K., Sugimoto, Y., & Ohno, R. (2009). Erratum: CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells (Leukemia (2009) vol. 23 (1329-1336) 10.1038/leukemia.2009.77). Leukemia, 23(7), 1372. https://doi.org/10.1038/leu.2009.115

Takeshita, A, Yamakage, N, Shinjo, K, Ono, T, Hirano, I, Nakamura, S, Shigeno, K, Tobita, T, Maekawa, M, Kiyoi, H, Naoe, T, Ohnishi, K, Sugimoto, Y & Ohno, R 2009, 'Erratum: CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells (Leukemia (2009) vol. 23 (1329-1336) 10.1038/leukemia.2009.77)', Leukemia, vol. 23, no. 7, pp. 1372. https://doi.org/10.1038/leu.2009.115

@article{1f2d792daf2847d6ba4549424077dc4f,

title = "Erratum: CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells (Leukemia (2009) vol. 23 (1329-1336) 10.1038/leukemia.2009.77)",

author = "A. Takeshita and N. Yamakage and K. Shinjo and T. Ono and I. Hirano and S. Nakamura and K. Shigeno and T. Tobita and M. Maekawa and H. Kiyoi and T. Naoe and K. Ohnishi and Y. Sugimoto and R. Ohno",

year = "2009",

doi = "10.1038/leu.2009.115",

language = "English",

volume = "23",

pages = "1372",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells (Leukemia (2009) vol. 23 (1329-1336) 10.1038/leukemia.2009.77)

AU - Takeshita, A.

AU - Yamakage, N.

AU - Shinjo, K.

AU - Ono, T.

AU - Hirano, I.

AU - Nakamura, S.

AU - Shigeno, K.

AU - Tobita, T.

AU - Maekawa, M.

AU - Kiyoi, H.

AU - Naoe, T.

AU - Ohnishi, K.

AU - Sugimoto, Y.

AU - Ohno, R.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=67650868986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650868986&partnerID=8YFLogxK

U2 - 10.1038/leu.2009.115

DO - 10.1038/leu.2009.115

M3 - Comment/debate

AN - SCOPUS:67650868986

SN - 0887-6924

VL - 23

SP - 1372

JO - Leukemia

JF - Leukemia

IS - 7

ER -